Efficacy of micronized flavonoid fraction in healing of clean and infected wounds

International Journal of Angiology

Volumn 10, Issue 1, 2001, Pages 41-44

  Hasanoglu, Adnan ^a,b   Ara, Cengiz ^a   Ozen, Suleyman ^a   Kali, Kenan ^a   Senol, Mustafa ^a   Ertas, Ertugrul ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GUINEA PIG; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SKIN SURFACE; STAPHYLOCOCCUS AUREUS; TOPICAL TREATMENT; TREATMENT OUTCOME; WOUND CARE; WOUND HEALING; WOUND INFECTION;

EID: 0035725655     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01616343     Document Type: Article

References (29)

1. Vital capillaroscopy on microcirculation: Pharmacodynamic activity of Daflon 500 mg in venous insufficiency
2. Pharmacodynamic properties and therapeutic efficacy of Daflon 500 mg
3. Capillary filtration in idiopathic cyclic edema- Effects of Daflon 500 mg
4. Microvascular reactivity after ischemia/reperfusion in the hamster cheek pouch: Beneficial effects of different oral doses of S-5682 (Daflon 500 mg)
5. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch
6. Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol
7. Biology of wound healing
8. Antioxidant activity of micronized diosmin on oxygen species from stimulated human neutrophils
9. Action of S5682 on the complemant system (in vitro and in vivo study)
10. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: In vivo observations in the hamster skin fold
11. Techniques used to evaluate the cutaneous microcirculation: Application of photoplethysmography to the assessment of a phlebotropic agent in the treatment of leg ulcers
12. Benefit of a 2-month treatment with a micronized, purified flavonoidic fraction on venous ulcer healing. A randomized, double-blind, controlled versus placebo trial
13. Wound healing
14. Felix Fleischner Lecture. The traffic of polymorphonuclear leucoytes through pulmonary microvessels in health and disease
15. Postischemic leukocyte/endothelial cell interactions and microvascular barrier dysfunction in skeletal muscle: Cellular mechanisms and effect of Daflon 500 mg
16. Adhesion molecule expression in post-ischemic microvascular dysfunction: Activity of a micronized purified flavonoid fraction
17. Pharmacologic properties of Daflon 500 mg
18. Mechanism of oedema: Activity of Daflon 500 mg
19. Evaluation of haemorheological and microcirculatory disturbances in chronic venous insufficiency: Activity of Daflon 500 mg
20. Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study
21. Effects of Daflon 500 mg on postischemic macromolecular leak syndrome in striated skin muscle of the hamster
22. Efficacy of Daflon 500 mg in the treatment of lymphedema (secondary to conventional therapy of breast cancer)
23. Daflon 500 mg depresses bradykinin-ischemia-induced microvascular leakage of FITC dextran in rat cremaster muscle
24. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders
25. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin
26. Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination
27. Chemoprevention of 4-nitro-quinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination
28. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg
29. Venous tone: Are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg